Cahill Financial Advisors’s Pulmonx LUNG Stock Holding History

Cahill Financial Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50	Closed	-$2K	–	524
2021 Q3	$2K	Buy	+50	New	+$1.97K	﹤0.01%	791

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MGM

Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cahill Financial Advisors's LUNG Position: Q4 2021 in Review

Cahill Financial Advisors sold out of Pulmonx (LUNG) in Q4 2021, closing a stake of 50 shares — an estimated $2K sold.

Cahill Financial Advisors first reported a position in LUNG in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 114 funds tracked by Wall St. Rank hold LUNG as of Q4 2021.

Cahill Financial Advisors reported no remaining Pulmonx position as of Q4 2021 after selling out during the quarter.
Cahill Financial Advisors sold 50 Pulmonx shares in Q4 2021, an estimated $2K.
Cahill Financial Advisors first reported a position in Pulmonx in Q3 2021 and held it in 1 quarter.
Cahill Financial Advisors's Pulmonx position peaked at $2K in Q3 2021.
114 funds tracked by Wall St. Rank held Pulmonx as of Q4 2021.

Based on Cahill Financial Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.